Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
- PMID: 27043634
- PMCID: PMC4931664
- DOI: 10.3390/cells5020015
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Abstract
Nuclear factor-κB (NF-κB) is a transcription factor that plays a crucial role in various biological processes, including immune response, inflammation, cell growth and survival, and development. NF-κB is critical for human health, and aberrant NF-κB activation contributes to development of various autoimmune, inflammatory and malignant disorders including rheumatoid arthritis, atherosclerosis, inflammatory bowel diseases, multiple sclerosis and malignant tumors. Thus, inhibiting NF-κB signaling has potential therapeutic applications in cancer and inflammatory diseases.
Keywords: NF-κB; cancer; canonical pathway; inflammatory disease; non-canonical pathway; therapeutic approaches.
Figures
Similar articles
-
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?Arthritis Res Ther. 2015 Jan 28;17(1):15. doi: 10.1186/s13075-015-0527-3. Arthritis Res Ther. 2015. PMID: 25774937 Free PMC article. Review.
-
The non-canonical NF-κB pathway in immunity and inflammation.Nat Rev Immunol. 2017 Sep;17(9):545-558. doi: 10.1038/nri.2017.52. Epub 2017 Jun 5. Nat Rev Immunol. 2017. PMID: 28580957 Free PMC article. Review.
-
Aqueous synthesized quantum dots interfere with the NF-κB pathway and confer anti-tumor, anti-viral and anti-inflammatory effects.Biomaterials. 2016 Nov;108:187-96. doi: 10.1016/j.biomaterials.2016.08.047. Epub 2016 Aug 31. Biomaterials. 2016. PMID: 27639114
-
The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment.Acta Biochim Pol. 2008;55(4):629-47. Epub 2008 Dec 16. Acta Biochim Pol. 2008. PMID: 19081854 Review.
-
IkappaB kinases: key regulators of the NF-kappaB pathway.Trends Biochem Sci. 2004 Feb;29(2):72-9. doi: 10.1016/j.tibs.2003.12.003. Trends Biochem Sci. 2004. PMID: 15102433 Review.
Cited by
-
Unlocking vinpocetine's oncostatic potential in early-stage hepatocellular carcinoma: A new approach to oncogenic modulation by a nootropic drug.PLoS One. 2024 Oct 31;19(10):e0312572. doi: 10.1371/journal.pone.0312572. eCollection 2024. PLoS One. 2024. PMID: 39480853 Free PMC article.
-
Navigating the Cytokine Seas: _targeting Cytokine Signaling Pathways in Cancer Therapy.Int J Mol Sci. 2024 Jan 13;25(2):1009. doi: 10.3390/ijms25021009. Int J Mol Sci. 2024. PMID: 38256080 Free PMC article. Review.
-
Pseudolaric Acid B _targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells.Int J Mol Sci. 2024 Jun 13;25(12):6517. doi: 10.3390/ijms25126517. Int J Mol Sci. 2024. PMID: 38928225 Free PMC article.
-
The relationship between NFKB, HER2, ER expression and anthracycline -based neoadjuvan chemotherapy response in local advanced stadium breast cancer: A cohort study in Eastern Indonesia.Ann Med Surg (Lond). 2021 Feb 10;63:102164. doi: 10.1016/j.amsu.2021.02.010. eCollection 2021 Mar. Ann Med Surg (Lond). 2021. PMID: 33664949 Free PMC article.
-
The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management.Cancers (Basel). 2024 Jul 18;16(14):2580. doi: 10.3390/cancers16142580. Cancers (Basel). 2024. PMID: 39061221 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources